Cargando…

Patterns of distant metastases in patients with clear cell renal cell carcinoma––A population‐based analysis

We developed this study to describe the patterns of distant metastasis (DM) and explore the predictive and prognostic factors of DM in clear cell renal cell carcinoma (ccRCC) patients. We collected the eligible patients from the Surveillance, Epidemiology, and End Result (SEER) database from 2010 to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xue, Jianxin, Chen, Wensun, Xu, Wenbo, Xu, Zicheng, Li, Xiao, Qi, Feng, Wang, Zengjun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826458/ https://www.ncbi.nlm.nih.gov/pubmed/33247630 http://dx.doi.org/10.1002/cam4.3596

Ejemplares similares

Patterns of distant metastases in 215 Merkel cell carcinoma patients: Implications for prognosis and surveillance
por: Lewis, Christopher W., et al.
Publicado: (2019)

Pattern and prognosis of distant metastases in nasopharyngeal carcinoma: A large‐population retrospective analysis
por: Qu, Weiling, et al.
Publicado: (2020)

Pattern of distant metastases in primary extrahepatic bile‐duct cancer: A SEER‐based study
por: Wang, Xuan, et al.
Publicado: (2018)

A prognostic nomogram based on competing endogenous RNA network for clear‐cell renal cell carcinoma
por: Peng, Yun, et al.
Publicado: (2021)

The prognosis and clinicopathological features of different distant metastases patterns in renal cell carcinoma: analysis based on the SEER database
por: Wei, Haibin, et al.
Publicado: (2021)

Pattern and risk factors for distant metastases in gastrointestinal neuroendocrine neoplasms: a population‐based study
por: Cai, Wen, et al.
Publicado: (2018)

CCR5 blockade inflames antitumor immunity in BAP1-mutant clear cell renal cell carcinoma
por: Zhou, Quan, et al.
Publicado: (2020)

MicroRNA‐194 is a Marker for Good Prognosis in Clear Cell Renal Cell Carcinoma
por: Nofech‐Mozes, Roy, et al.
Publicado: (2016)

Comprehensive subgroup analyses of survival outcomes between clear cell renal cell adenocarcinoma and papillary renal cell adenocarcinoma
por: Huang, Jingyi, et al.
Publicado: (2020)

Association of radiation dose intensity with overall survival in patients with distant metastases
por: Kao, Johnny, et al.
Publicado: (2021)

A MUCINs expression signature impacts overall survival in patients with clear cell renal cell carcinoma
por: Meng, Hui, et al.
Publicado: (2021)

Comprehensive insights on pivotal prognostic signature involved in clear cell renal cell carcinoma microenvironment using the ESTIMATE algorithm
por: Luo, Jun, et al.
Publicado: (2020)

Influence of gene expression on survival of clear cell renal cell carcinoma
por: Berglund, Anders, et al.
Publicado: (2020)

Construction and validation of an autophagy‐related long noncoding RNA signature for prognosis prediction in kidney renal clear cell carcinoma patients
por: Yu, JunJie, et al.
Publicado: (2021)

Low level of Cyclin‐D1 correlates with worse prognosis of clear cell renal cell carcinoma patients
por: Wang, Qing‐shui, et al.
Publicado: (2019)

Development and validation of a PBRM1‐associated immune prognostic model for clear cell renal cell carcinoma
por: Chen, Jiayi, et al.
Publicado: (2021)

Overweight and obesity predict better overall survival rates in cancer patients with distant metastases
por: Tsang, Ngan Ming, et al.
Publicado: (2016)

Geospatial characterization of immune cell distributions and dynamics across the microenvironment in clear cell renal cell carcinoma
por: Chakiryan, Nicholas H, et al.
Publicado: (2023)

Conditional survival of metastatic clear cell renal cell carcinoma: How prognosis evolves after cytoreductive surgery of primary tumor
por: Shen, Haixiang, et al.
Publicado: (2021)

Characteristics of contrast‐enhanced ultrasound for diagnosis of solid clear cell renal cell carcinomas ≤4 cm: A meta‐analysis
por: Liu, Yang, et al.
Publicado: (2021)

CCL2 as a potential therapeutic target for clear cell renal cell carcinoma
por: Arakaki, Ryuichiro, et al.
Publicado: (2016)

Etiologic heterogeneity of clear‐cell and papillary renal cell carcinoma in the Netherlands Cohort Study
por: van de Pol, Jeroen A. A., et al.
Publicado: (2020)

Characterizing Tumor Thrombus Arising from Non–Clear Cell Renal Cell Carcinoma
por: Rabinowitz, Matthew J., et al.
Publicado: (2022)

Intratumoral fibrosis and patterns of immune infiltration in clear cell renal cell carcinoma
por: Han, Songchen, et al.
Publicado: (2022)

Heart Metastases of Clear Cell Renal Cell Carcinoma
por: Romejko, Katarzyna, et al.
Publicado: (2023)

High frequency of lobular breast cancer in distant metastases to the orbit
por: Raap, Mieke, et al.
Publicado: (2015)

Survival and clinical prognostic factors in metastatic non‐clear cell renal cell carcinoma treated with targeted therapy: A multi‐institutional, retrospective study using the Korean metastatic renal cell carcinoma registry
por: Kim, Jung Kwon, et al.
Publicado: (2019)

Eosinophilic features in clear cell renal cell carcinoma correlate with outcomes of immune checkpoint and angiogenesis blockade
por: Yoshida, Takashi, et al.
Publicado: (2021)

Systematic Evaluation of the Prognostic Impact and Intratumour Heterogeneity of Clear Cell Renal Cell Carcinoma Biomarkers
por: Gulati, Sakshi, et al.
Publicado: (2014)

First-Line Treatments for Metastatic Clear Cell Renal Cell Carcinoma: An Ever-Enlarging Landscape
por: Gulati, Shuchi, et al.
Publicado: (2022)

RUNX1/miR-582-5p Pathway Regulates the Tumor Progression in Clear Cell Renal Cell Carcinoma by Targeting COL5A1
por: Xue, Jianxin, et al.
Publicado: (2021)

Functional and genomic characterization of patient‐derived xenograft model to study the adaptation to mTORC1 inhibitor in clear cell renal cell carcinoma
por: Sakamoto, Hiromasa, et al.
Publicado: (2020)

DNA damage repair pathway alterations in metastatic clear cell renal cell carcinoma and implications on systemic therapy
por: Ged, Yasser, et al.
Publicado: (2020)

Abnormal oxidative metabolism in a quiet genomic background underlies clear cell papillary renal cell carcinoma
por: Xu, Jianing, et al.
Publicado: (2019)

Identification of small molecule drugs and development of a novel autophagy‐related prognostic signature for kidney renal clear cell carcinoma
por: Xing, Qianwei, et al.
Publicado: (2020)

Tumor signatures of PTHLH overexpression, high serum calcium, and poor prognosis were observed exclusively in clear cell but not non clear cell renal carcinomas
por: Yao, Masahiro, et al.
Publicado: (2014)

Simultaneous Bilateral Testicular Metastases from Renal Clear Cell Carcinoma: A Rare Presentation in Von Hippel–Lindau disease
por: Moradi, Asaad, et al.
Publicado: (2022)

The association of immunosurveillance and distant metastases in colorectal cancer
por: Jacob, Sven, et al.
Publicado: (2021)

Basic Characteristics and Survival Outcomes of Asian-American Patients with Clear Cell Renal Cell Carcinoma and Comparisons with White Patients: A Population-Based Analysis
por: Li, Xiao, et al.
Publicado: (2021)

Preclinical evaluation of an unconventional ruthenium‐gold‐based chemotherapeutic: RANCE‐1, in clear cell renal cell carcinoma
por: Elie, Benelita T., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_p0q5vp0r2i2p0a72iqkerrst35